American Journal of Industrial Medicine · 2007 · 69 citations · 36 references
PharmacyNeuroscienceToxicologyHeavy Metal ToxicologyNeurochemistryNeurotoxicologyBasal GangliaEnvironmental NeurotoxicologyHeavy Metal NeurotoxicityManganese ToxicityManganese ToxicologyParkinson DiseaseBasal Ganglia DamageBasal Ganglia ToxicityBrain Manganese AccumulationHeavy Metal Neurotoxicity AssessmentManganese OverexposureNeurotransmitter DisruptionNeurotransmitter PharmacologyOccupational Manganese Exposure
BACKGROUND: Manganese neurotoxicity in humans is recognized as a form of parkinsonism with lesions occurring predominantly within the globus pallidus, subthalamic nucleus, putamen, and caudate nucleus. METHODS: This study evaluated dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, serotonin, norepinephrine, 5-hydroxyindoleacetic acid, gamma-aminobutyric acid (GABA), and glutamate concentrations in the globus pallidus, caudate, and putamen of male rhesus monkeys exposed subchronically to either air or manganese sulfate (MnSO4) at 0.06, 0.3, or 1.5 mg Mn/m3. RESULTS: An approximate 1.5-6-fold increase (vs. air-exposed controls) in mean brain manganese concentration was observed following subchronic MnSO4 exposure. A marginally significant (P < 0.1) decrease in pallidal GABA and 5-hydroxyindoleacetic acid concentration and caudate norepinephrine concentration occurred in monkeys exposed to MnSO4 at 1.5 mg Mn/m3. CONCLUSIONS: Despite the presence of increased tissue manganese concentrations, high-dose exposure to MnSO4 was associated with relatively few changes in basal ganglial neurotransmitter concentrations.
36
The 1996 Guide for the Care and Use of Laboratory Animals
J. Derrell Clark, Gerald F. Gebhart, Janet C. Gonder et al. · ILAR Journal · 1997 · 4.4K citations · Full text